Biorevitalisation
SUNEKOS references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 13656
Sunekos Cell 15
Sunekos Cell 15 is an effective solution that targets Edematous Fibrosclerotic Panniculopathy (EFP) in stages I–IV. It restructures the extracellular matrix to improve microcirculation and reduce fibrosis.
In stock
Laboratory
Professional Dietetics S.p.A.
Origin
Italy
Indication
Cellulite, EFP, stages I to IV
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is typically applied by clinics, dermatologists and aesthetic practitioners treating cellulite, framed by the manufacturer as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product is based on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach, and is intended for professional use by qualified practitioners.
Key Benefits of Sunekos Cell 15
- CE-marked Class III medical device under EU MDR 2017/745, notified body 0373
- Promotes optimisation of extracellular matrix protein turnover
- Supports neo-collagenesis rather than collagenase
- Helps improve microcirculation
- Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
- Helps regulate physiological pH
- Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
- Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
Indications and Professional Use
Main indications
- Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
- Cellulite stages I and II
- Cellulite stages III and IV
- Fibrosis and extracellular matrix inflammation associated with cellulite
- Impaired microcirculation associated with cellulite
Professional use
Sunekos Cell 15 is a Class III medical device supplied for professional use only and must be administered by qualified medical practitioners. The product is supplied as a treatment pack to be reconstituted before use, combining a carbonate/bicarbonate vial with a low molecular weight sodium hyaluronate and amino acid bottle; reconstitution must follow the manufacturer's instructions exactly. The treating practitioner determines patient suitability, cellulite staging, treated zone, injection plane, dose per point and session interval. Aseptic technique applies throughout, the pack is single-use, and any unused reconstituted solution is discarded. Contraindications, warnings and precautions must be followed as stated in the manufacturer's Instructions For Use.
Treatment areas
- Body areas affected by cellulite, staged clinically before treatment
Patient profile
Sunekos Cell 15 is intended for adult patients presenting with cellulite, which the manufacturer frames as Edematous Fibrosclerotic Panniculopathy, and the official indications cover both stages I and II and stages III and IV. The preliminary study reported by the manufacturer was conducted on 25 healthy subjects, 11 with stages I and II and 14 with stages III and IV. Staging and suitability are determined by the treating practitioner following clinical assessment. Patients with known hypersensitivity to hyaluronic acid or to any amino acid component, active infection or inflammation at the intended injection site, or any condition listed as a contraindication in the Instructions For Use must not be treated.
How Sunekos Cell 15 Works
Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, described by the manufacturer as rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.
Why Order From Allpara
Allpara offers genuine, verified SUNEKOS products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
Which cellulite stages does Sunekos Cell 15 treat?
Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.
How does Sunekos Cell 15 differ from lipolytic cellulite treatments?
Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach the manufacturer describes as rebuilding rather than destroying.
What does Sunekos Cell 15 contain?
Sunekos Cell 15 is built on a synergy of hyaluronic acid, amino acids and an alkaline solution. It is supplied as a 15 ml treatment pack to be reconstituted, containing one carbonate/bicarbonate vial and one bottle of low molecular weight sodium hyaluronate with amino acids.
Is there clinical data for Sunekos Cell 15?
The manufacturer reports a preliminary study on 25 healthy subjects with different cellulite stages, evaluated clinically, morphometrically and by ultrasound at baseline, one month and four months after treatment. The reported conclusions were a reduction in clinical evaluation score in both stage groups and maintenance of results after four months.
Why does Sunekos Cell 15 include an alkaline solution?
The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which the manufacturer links to reducing the fibrosis component of cellulite.
More from Professional Dietetics
Skin Boosters
Clinic alternatives
Mesotherapy
/ Recently viewed
Pick up where you left off
Sunekos Cell 15
In stock
CE Marked
Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is typically applied by clinics, dermatologists and aesthetic practitioners treating cellulite, framed by the manufacturer as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product is based on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach, and is intended for professional use by qualified practitioners.
Key Benefits of Sunekos Cell 15
- CE-marked Class III medical device under EU MDR 2017/745, notified body 0373
- Promotes optimisation of extracellular matrix protein turnover
- Supports neo-collagenesis rather than collagenase
- Helps improve microcirculation
- Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
- Helps regulate physiological pH
- Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
- Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
Indications and Professional Use
Main indications
- Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
- Cellulite stages I and II
- Cellulite stages III and IV
- Fibrosis and extracellular matrix inflammation associated with cellulite
- Impaired microcirculation associated with cellulite
Professional use
Sunekos Cell 15 is a Class III medical device supplied for professional use only and must be administered by qualified medical practitioners. The product is supplied as a treatment pack to be reconstituted before use, combining a carbonate/bicarbonate vial with a low molecular weight sodium hyaluronate and amino acid bottle; reconstitution must follow the manufacturer's instructions exactly. The treating practitioner determines patient suitability, cellulite staging, treated zone, injection plane, dose per point and session interval. Aseptic technique applies throughout, the pack is single-use, and any unused reconstituted solution is discarded. Contraindications, warnings and precautions must be followed as stated in the manufacturer's Instructions For Use.
Treatment areas
- Body areas affected by cellulite, staged clinically before treatment
Patient profile
Sunekos Cell 15 is intended for adult patients presenting with cellulite, which the manufacturer frames as Edematous Fibrosclerotic Panniculopathy, and the official indications cover both stages I and II and stages III and IV. The preliminary study reported by the manufacturer was conducted on 25 healthy subjects, 11 with stages I and II and 14 with stages III and IV. Staging and suitability are determined by the treating practitioner following clinical assessment. Patients with known hypersensitivity to hyaluronic acid or to any amino acid component, active infection or inflammation at the intended injection site, or any condition listed as a contraindication in the Instructions For Use must not be treated.
How Sunekos Cell 15 Works
Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, described by the manufacturer as rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.
Why Order From Allpara
Allpara offers genuine, verified SUNEKOS products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
Which cellulite stages does Sunekos Cell 15 treat?
Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.
How does Sunekos Cell 15 differ from lipolytic cellulite treatments?
Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach the manufacturer describes as rebuilding rather than destroying.
What does Sunekos Cell 15 contain?
Sunekos Cell 15 is built on a synergy of hyaluronic acid, amino acids and an alkaline solution. It is supplied as a 15 ml treatment pack to be reconstituted, containing one carbonate/bicarbonate vial and one bottle of low molecular weight sodium hyaluronate with amino acids.
Is there clinical data for Sunekos Cell 15?
The manufacturer reports a preliminary study on 25 healthy subjects with different cellulite stages, evaluated clinically, morphometrically and by ultrasound at baseline, one month and four months after treatment. The reported conclusions were a reduction in clinical evaluation score in both stage groups and maintenance of results after four months.
Why does Sunekos Cell 15 include an alkaline solution?
The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which the manufacturer links to reducing the fibrosis component of cellulite.
More from Professional Dietetics
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.